モルペス細粒２％
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00295 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 100 |
| 日本商品名（例） | モルヒネ硫酸塩水和物徐放細粒分包１０ｍｇ「フジモト」, モルヒネ硫酸塩水和物徐放細粒分包３０ｍｇ「フジモト」, モルペス細粒２％ |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | myofascial pain syndrome | 99% | DL |
| 2 | manic bipolar affective disorder | 99% | DL |
| 3 | Tourette syndrome | 99% | DL |
| 4 | restless legs syndrome | 99% | DL |
| 5 | attention deficit hyperactivity disorder, inattentive type | 99% | DL |
| 6 | migraine disorder | 99% | DL |
| 7 | trichotillomania | 99% | DL |
| 8 | schizophreniform disorder | 99% | DL |
| 9 | methemoglobinemia | 99% | DL |
| 10 | migraine with brainstem aura | 99% | DL |
| 11 | specific developmental disorder | 99% | DL |
| 12 | idiopathic granulomatous myositis | 99% | DL |
| 13 | myositis fibrosa | 99% | DL |
| 14 | tendinitis | 99% | DL |
| 15 | fibromyalgia | 98% | DL |
| 16 | inclusion body myositis | 98% | DL |
| 17 | visual epilepsy | 98% | DL |
| 18 | cluster headache syndrome | 98% | DL |
| 19 | headache disorder | 98% | DL |
| 20 | schizoaffective disorder | 98% | DL |
| 21 | methemoglobinemia, alpha type | 98% | DL |
| 22 | mixed anxiety and depressive disorder | 98% | DL |
| 23 | nicotine dependence | 97% | DL |
| 24 | mental disorder | 97% | DL |
| 25 | nephrogenic syndrome of inappropriate antidiuresis | 97% | DL |
| 26 | bipolar disorder | 97% | DL |
| 27 | orgasm-induced seizures | 97% | DL |
| 28 | eating seizures | 97% | DL |
| 29 | thinking seizures | 97% | DL |
| 30 | audiogenic seizures | 97% | DL |
| 31 | startle epilepsy | 97% | DL |
| 32 | micturation-induced seizures | 97% | DL |
| 33 | methemoglobin reductase deficiency | 97% | DL |
| 34 | reading seizures | 97% | DL |
| 35 | trigeminal autonomic cephalalgia | 97% | DL |
| 36 | atrophoderma vermiculata | 97% | DL |
| 37 | chondromyxoid fibroma | 97% | DL |
| 38 | psychotic disorder | 97% | DL |
| 39 | trigeminal nerve neoplasm | 97% | DL |
| 40 | obsolete vascular headache | 96% | DL |
| 41 | major affective disorder | 96% | DL |
| 42 | skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | 96% | DL |
| 43 | hemicrania continua | 96% | DL |
| 44 | neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | 96% | DL |
| 45 | common cold | 96% | DL |
| 46 | ulerythema ophryogenesis | 96% | DL |
| 47 | sciatic neuropathy | 96% | DL |
| 48 | methemoglobinemia due to deficiency of methemoglobin reductase | 96% | DL |
| 49 | partial deletion of the short arm of chromosome 4 | 96% | DL |
| 50 | postpartum psychosis | 96% | DL |
（上位50件を表示。全100件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。